Reviv3 Procare Reports Executive Compensation Changes

TL;DR

**Reviv3 Procare just changed exec pay, watch for leadership shifts.**

AI Summary

Reviv3 Procare Co. filed an 8-K on February 6, 2024, reporting an event that occurred on January 31, 2024, related to changes in its executive compensation arrangements. This filing indicates potential shifts in how the company incentivizes its leadership, which could impact future financial performance and governance. For investors, understanding these changes is crucial as they can influence management's motivation and the company's operational stability.

Why It Matters

Changes in executive compensation can signal shifts in company strategy or financial health, directly impacting investor confidence and the stock's perceived value.

Risk Assessment

Risk Level: medium — Changes in executive compensation can introduce uncertainty regarding leadership stability and future strategic direction, posing a moderate risk to investors.

Analyst Insight

A smart investor would monitor subsequent filings or company announcements for specific details regarding the changes in compensatory arrangements, as these details will clarify the impact on company strategy and executive incentives.

Key Players & Entities

• Reviv3 Procare Co. (company) — the registrant filing the 8-K
• January 31, 2024 (date) — date of the earliest event reported
• February 6, 2024 (date) — date the 8-K was filed

Forward-Looking Statements

• Reviv3 Procare Co. will provide more details on specific executive compensation changes in future filings or press releases. (Reviv3 Procare Co.) — medium confidence, target: 2024-03-31

FAQ

Filing Documents

• rviv-20240206_8k.htm (8-K) — 37KB
• 0001520138-24-000057.txt ( ) — 201KB
• rviv-20240131_pre.xml (EX-101.PRE) — 22KB
• rviv-20240131.xsd (EX-101.SCH) — 3KB
• rviv-20240131_lab.xml (EX-101.LAB) — 33KB
• rviv-20240206_8k_htm.xml (XML) — 3KB

Forward Looking Statements

Forward Looking Statements This Current Report on Form 8-K contains certain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements represent our expectations, beliefs, intentions or strategies concerning future events, including, but not limited to, any statements regarding the NYSE American Listing, of which is subject to various risks and uncertainties. When used in this Current Report and Form 8-K, the words or phrases "will," "expected," or similar expressions and variations thereof are intended to identify such forward-looking to be forward-looking statements. Furthermore, such forward-looking statements speak only as of the date of this Current Report and Form 8-K. We caution that these statements by their nature involve risks and uncertainties, certain of which are beyond our control, and actual results may differ materially depending on a variety of important factors. For example, there can be no assurance that the Reverse Stock Split will be successful. These forward-looking statements are not guarantees of our future performance and involve risks, uncertainties, estimates and assumptions that are difficult to predict. We do not assume the obligation to update any forward-looking statement, except as required by applicable law.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. REVIV3 PROCARE COMPANY Date: February 6, 2024 /s/ Jeff Toghraie Name: Jeff Toghraie Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR